The first cases of collagenous sprue successfully treated with thioguanine

Objective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this s...

Full description

Saved in:
Bibliographic Details
Main Authors: Chris J J Mulder, Gerd Bouma, Tom van Gils, Tine van de Donk, Foke van Delft, E Andra Neefjes-Borst
Format: Article
Language:English
Published: BMJ Publishing Group 2016-06-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/3/1/e000099.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857154162950144
author Chris J J Mulder
Gerd Bouma
Tom van Gils
Tine van de Donk
Foke van Delft
E Andra Neefjes-Borst
author_facet Chris J J Mulder
Gerd Bouma
Tom van Gils
Tine van de Donk
Foke van Delft
E Andra Neefjes-Borst
author_sort Chris J J Mulder
collection DOAJ
description Objective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this series is to describe 4 cases of CS and to propose thioguanine (6-TG) treatment.Design We reviewed 4 cases of CS. Data were obtained from our prospective database of patients referred to our coeliac centre. Evaluation of small bowel biopsies was performed by an expert pathologist.Results None of the patients had ever had coeliac-specific antibodies, and all were negative for HLA-DQ2 and HLA-DQ8 phenotype. Three patients were treated with a combination of 6-TG and budesonide, and 1 patient received 6-TG only. All patients improved remarkably. Normalisation of the thickened basement membrane was found in 2 patients and complete histological improvement including full recovery of villi was found in 1 patient. In the third patient, the thickened basement membrane was only very focally recognised. The thickened membrane persisted in the last patient, probably because of the short time of follow-up.Conclusions CS should be separated from coeliac disease. Based on the lack of typical HLA phenotyping and the absence of coeliac-specific antibodies, there seems to be no relation with coeliac disease in these 4 cases. A promising treatment option might be 6-TG with or without budesonide. Research in a larger cohort is needed to standardise treatment for CS.
format Article
id doaj-art-af8fea49ba614afa9e432323fcbf98c4
institution Kabale University
issn 2054-4774
language English
publishDate 2016-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-af8fea49ba614afa9e432323fcbf98c42025-02-11T23:10:10ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742016-06-013110.1136/bmjgast-2016-000099The first cases of collagenous sprue successfully treated with thioguanineChris J J Mulder0Gerd Bouma1Tom van Gils2Tine van de Donk3Foke van Delft4E Andra Neefjes-Borst53 Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands7 Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands2Department of Pathology, VU University Medical Center, Amsterdam, The NetherlandsObjective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this series is to describe 4 cases of CS and to propose thioguanine (6-TG) treatment.Design We reviewed 4 cases of CS. Data were obtained from our prospective database of patients referred to our coeliac centre. Evaluation of small bowel biopsies was performed by an expert pathologist.Results None of the patients had ever had coeliac-specific antibodies, and all were negative for HLA-DQ2 and HLA-DQ8 phenotype. Three patients were treated with a combination of 6-TG and budesonide, and 1 patient received 6-TG only. All patients improved remarkably. Normalisation of the thickened basement membrane was found in 2 patients and complete histological improvement including full recovery of villi was found in 1 patient. In the third patient, the thickened basement membrane was only very focally recognised. The thickened membrane persisted in the last patient, probably because of the short time of follow-up.Conclusions CS should be separated from coeliac disease. Based on the lack of typical HLA phenotyping and the absence of coeliac-specific antibodies, there seems to be no relation with coeliac disease in these 4 cases. A promising treatment option might be 6-TG with or without budesonide. Research in a larger cohort is needed to standardise treatment for CS.https://bmjopengastro.bmj.com/content/3/1/e000099.full
spellingShingle Chris J J Mulder
Gerd Bouma
Tom van Gils
Tine van de Donk
Foke van Delft
E Andra Neefjes-Borst
The first cases of collagenous sprue successfully treated with thioguanine
BMJ Open Gastroenterology
title The first cases of collagenous sprue successfully treated with thioguanine
title_full The first cases of collagenous sprue successfully treated with thioguanine
title_fullStr The first cases of collagenous sprue successfully treated with thioguanine
title_full_unstemmed The first cases of collagenous sprue successfully treated with thioguanine
title_short The first cases of collagenous sprue successfully treated with thioguanine
title_sort first cases of collagenous sprue successfully treated with thioguanine
url https://bmjopengastro.bmj.com/content/3/1/e000099.full
work_keys_str_mv AT chrisjjmulder thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT gerdbouma thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT tomvangils thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT tinevandedonk thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT fokevandelft thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT eandraneefjesborst thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT chrisjjmulder firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT gerdbouma firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT tomvangils firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT tinevandedonk firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT fokevandelft firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine
AT eandraneefjesborst firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine